Similar articles for PMID: 31209163

Year	Number of Results
1999	1
2002	1
2006	1
2009	2
2010	7
2011	7
2012	5
2013	5
2014	7
2015	11
2016	8
2017	9
2018	15
2019	13
2020	15
2021	7
2022	7
2023	7
2024	0

1

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals.

Telikepalli S, Gonzalez K, Dragulin-Otto S, Ripple D, Carrier M, Khan M. Telikepalli S, et al. PDA J Pharm Sci Technol. 2019 Sep-Oct;73(5):418-432. doi: 10.5731/pdajpst.2018.008953. Epub 2019 Jun 17. PDA J Pharm Sci Technol. 2019. PMID: 31209163

2

Semi-Quantitative Analysis of Inherent Visible Particles for Biopharmaceutical Products.

Cash PW, Narwal R, Levitskaya SV, Krause S, Murphy D, Mazaheri M. Cash PW, et al. PDA J Pharm Sci Technol. 2016 Mar-Apr;70(2):134-42. doi: 10.5731/pdajpst.2015.006064. Epub 2016 Jan 21. PDA J Pharm Sci Technol. 2016. PMID: 26797974

3

An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards.

Telikepalli SN, Carrier MJ, Ripple DC, Barnett G, Bhirde A, Bolton D, Bou-Assaf GM, Ferrari E, Leigh S, Levitskaya-Seaman S, Menzen T, Nikels F, Riley A, Saggu M, Sahni N, Vernooij E, Wuchner K. Telikepalli SN, et al. AAPS PharmSciTech. 2022 Dec 16;24(1):18. doi: 10.1208/s12249-022-02457-9. AAPS PharmSciTech. 2022. PMID: 36526853

4

A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products.

Mathonet S, Mahler HC, Esswein ST, Mazaheri M, Cash PW, Wuchner K, Kallmeyer G, Das TK, Finkler C, Lennard A. Mathonet S, et al. PDA J Pharm Sci Technol. 2016 Jul-Aug;70(4):392-408. doi: 10.5731/pdajpst.2015.006189. Epub 2016 Apr 18. PDA J Pharm Sci Technol. 2016. PMID: 27091885 Review.

5

Introducing the Alba^® Primary Packaging Platform. Part 1: Particle Release Evaluation.

Chillon A, Pace A, Zuccato D. Chillon A, et al. PDA J Pharm Sci Technol. 2018 Jul-Aug;72(4):382-392. doi: 10.5731/pdajpst.2018.008623. Epub 2018 May 31. PDA J Pharm Sci Technol. 2018. PMID: 29853611

6

Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.

Akhunzada ZS, Hubert M, Sahin E, Pratt J. Akhunzada ZS, et al. Curr Pharm Biotechnol. 2019;20(3):232-244. doi: 10.2174/1389201020666190214100840. Curr Pharm Biotechnol. 2019. PMID: 30767738

7

Improving Diameter Accuracy for Dynamic Imaging Microscopy for Different Particle Types.

Cavicchi RE, Ripple DC; Bioprocess Measurements Group. Cavicchi RE, et al. J Pharm Sci. 2020 Jan;109(1):488-495. doi: 10.1016/j.xphs.2019.10.017. Epub 2019 Oct 16. J Pharm Sci. 2020. PMID: 31628920

8

A Case for Expanding Thermochromic Vial Monitor Technology to Insulin and Other Biologics.

Virmani A, Avni TCA. Virmani A, et al. Indian Pediatr. 2020 Jan 15;57(1):17-19. Indian Pediatr. 2020. PMID: 31937691 Free article.

9

Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.

Gruia F, Parupudi A, Polozova A. Gruia F, et al. PDA J Pharm Sci Technol. 2015 May-Jun;69(3):427-39. doi: 10.5731/pdajpst.2015.01051. PDA J Pharm Sci Technol. 2015. PMID: 26048748

10

Sub-visible particle quantitation in protein therapeutics.

Cao S, Jiao N, Jiang Y, Mire-Sluis A, Narhi LO. Cao S, et al. Pharmeur Bio Sci Notes. 2009 Oct;2009(1):73-9. Pharmeur Bio Sci Notes. 2009. PMID: 20144454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year